These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 657047)
1. Adverse biochemical and clinical consequences of furosemide administration. Spino M; Sellers EM; Kaplan HL; Stapleton C; MacLeod SM Can Med Assoc J; 1978 Jun; 118(12):1513-8. PubMed ID: 657047 [TBL] [Abstract][Full Text] [Related]
2. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294 [TBL] [Abstract][Full Text] [Related]
3. Furosemide-induced adverse reactions during hospitalization. Naranjo CA; Busto U; Cassis L Am J Hosp Pharm; 1978 Jul; 35(7):794-8. PubMed ID: 665695 [TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [TBL] [Abstract][Full Text] [Related]
5. Hypokalemia during the treatment of arterial hypertension with diuretics. Lemieux G; Beauchemin M; Vinay P; Gougoux A Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875 [TBL] [Abstract][Full Text] [Related]
6. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Noize P; Bagheri H; Durrieu G; Haramburu F; Moore N; Giraud P; Galinier M; Pourrat J; Montastruc JL Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):747-53. PubMed ID: 21438068 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with spironolactone in pediatrics. Buck ML Ann Pharmacother; 2005 May; 39(5):823-8. PubMed ID: 15811903 [TBL] [Abstract][Full Text] [Related]
8. [Prospective observational study of drug-induced hyperkalemia in hospitalized non dialized adult patients]. Onno C; Rémignon H; Lagarce L; Bruhat C; Tourmen Y; Subra JF; Lainé-Cessac P Therapie; 2007; 62(1):55-60. PubMed ID: 17374349 [TBL] [Abstract][Full Text] [Related]
9. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone. Abbas Z; Mumtaz K; Salam A; Jafri W J Coll Physicians Surg Pak; 2003 Jul; 13(7):382-4. PubMed ID: 12887837 [TBL] [Abstract][Full Text] [Related]
10. Serum potassium influencing interacting drugs: risk-modifying strategies also needed at discontinuation. Uijtendaal EV; Zwart-van Rijkom JE; van Solinge WW; Egberts TC Ann Pharmacother; 2012 Feb; 46(2):176-82. PubMed ID: 22298604 [TBL] [Abstract][Full Text] [Related]
11. Potassium and phosphorus repletion in hospitalized patients: implications for clinical practice and the potential use of healthcare information technology to improve prescribing and patient safety. Hemstreet BA; Stolpman N; Badesch DB; May SK; McCollum M Curr Med Res Opin; 2006 Dec; 22(12):2449-55. PubMed ID: 17257459 [TBL] [Abstract][Full Text] [Related]
12. [Hypokalemia, hypovolemia and electrocardiographic changes due to furosemide abuse. Report of one case]. Aravena C; Salas I; Tagle R; Jara A; Miranda R; McNab P; Rodríguez JA; Valdés G; Valdivieso A Rev Med Chil; 2007 Nov; 135(11):1456-62. PubMed ID: 18259658 [TBL] [Abstract][Full Text] [Related]
13. [Drug adverse effects in the elderly hospitalized with acute pathologies]. Beltrami GC; Menegolli GP; Corrà L; Weber U; Longobardi A; Albiero A; Conati GF; Grezzana M; Vecchiato D; Fusi F; Grezzana LG Clin Ter; 2000; 151(1):19-23. PubMed ID: 10822877 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of extreme hyperkalemia caused by diabetic ketoacidosis, potassium-sparing diuretics and potassium substitutes]. Nikolić-Djurović M; Marisavljević D; Popović-Brkić V; Mićić J Srp Arh Celok Lek; 1990; 118(9-10):407-10. PubMed ID: 2129365 [TBL] [Abstract][Full Text] [Related]
15. Clinical factors associated with hyperkalemia in patients with congestive heart failure. Ramadan FH; Masoodi N; El-Solh AA J Clin Pharm Ther; 2005 Jun; 30(3):233-9. PubMed ID: 15896240 [TBL] [Abstract][Full Text] [Related]
16. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. Shah KB; Rao K; Sawyer R; Gottlieb SS J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135 [TBL] [Abstract][Full Text] [Related]
17. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855 [TBL] [Abstract][Full Text] [Related]
18. Frequency of hypomagnesemia in hospitalized patients receiving digitalis. Whang R; Oei TO; Watanabe A Arch Intern Med; 1985 Apr; 145(4):655-6. PubMed ID: 3985729 [TBL] [Abstract][Full Text] [Related]